Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma

Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that infects at least 10 million people worldwide and is associated with the development of T-cell lymphoma (TCL). The treatment of TCL remains challenging and new treatment options are urgently needed. With the goal of developing a novel t...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Shariful, Espitia, Claudia M., Persky, Daniel O., Carew, Jennifer S., Nawrocki, Steffan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310324/
https://www.ncbi.nlm.nih.gov/pubmed/34372612
http://dx.doi.org/10.3390/v13071406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310324/
https://www.ncbi.nlm.nih.gov/pubmed/34372612
http://dx.doi.org/10.3390/v13071406

Ejemplares similares